Mark Hopkins

Global Franchise Head, Research and Development Intellectual Property at Novartis Institute for Biomedical Research | Oakland, California, United States

About Mark Hopkins

Dr. Mark Hopkins serves as the Global Franchise Head of Research and Development Intellectual Property at the Novartis Institute for Biomedical Research (NIBR), where he leverages over 25 years of experience as both a scientist and a lawyer in the chemical research and development sector. His unique blend of expertise in patent law and scientific research positions him at the forefront of intellectual property strategy within the life sciences industry. In his current role, Dr. Hopkins is responsible for advising and training teams on complex intellectual property issues, ensuring that innovative research is effectively protected and aligned with corporate goals.

One of his key projects involves the development and implementation of comprehensive intellectual property strategies that safeguard NIBR's groundbreaking research initiatives, particularly in the realms of genomics and biotechnology. He plays a pivotal role in negotiating agreements that facilitate collaboration across NIBR, China NIBR, and the Genomics Institute of the Novartis Research Foundation, fostering an environment of innovation and strategic partnerships. Dr. Hopkins’ extensive knowledge in patentability, patent prosecution, and trade secrets enables him to navigate the intricate landscape of patent litigation and due diligence, ensuring that Novartis remains a leader in the competitive pharmaceutical market.

With a strong foundation in corporate law and a deep understanding of the scientific process, Dr. Hopkins is not only a guardian of intellectual property but also a catalyst for advancing novel therapeutic solutions. His commitment to bridging the gap between science and law exemplifies his dedication to fostering innovation while protecting the intellectual assets that drive the future of medicine.

Mark Hopkins Work